Supplemental tables and figures of 'Tirzepatide immunogenicity on pharmacokinetics, efficacy, and safety: analysis of data from Phase 3 studies'

Name: Supplemental tables and figures of 'Tirzepatide immunogenicity on pharmacokinetics, efficacy, and safety: analysis of data from Phase 3 studies'
Creator: Garrett Mullins
Published: 2023-08-23T11:09:51.902Z
Keywords: Immunogenicity, Clinical Trial Results

Mullins, Garrett; Hodsdon, Michael E.; Li, Ying Grace; Anglin, Greg; Urva, Shweta; Schneck, Karen; Bardos, Jennifer N.; Fonseca Martins, Ricardo; Brown, Katelyn; Calderon, Boris

doi:10.17632/dxthnf38zx.1

Supplemental tables and figures of 'Tirzepatide immunogenicity on pharmacokinetics, efficacy, and safety: analysis of data from Phase 3 studies'

Published: 23 August 2023| Version 1 | DOI: 10.17632/dxthnf38zx.1

Contributors:

, Michael E. Hodsdon, Ying Grace Li, Greg Anglin, Shweta Urva, Karen Schneck, Jennifer N. Bardos, Ricardo Fonseca Martins, Katelyn Brown, Boris Calderon

Description

Supplemental tables and figures of 'Tirzepatide immunogenicity on pharmacokinetics, efficacy, and safety: analysis of data from Phase 3 studies'

Files

Funding

Eli Lilly (United States)

Supplemental tables and figures of 'Tirzepatide immunogenicity on pharmacokinetics, efficacy, and safety: analysis of data from Phase 3 studies'

Description

Files

Categories

Funding

Licence